Advertisement

Topics

Arena Pharmaceuticals Completes Trial Comparing Once-Daily, Extended Release Formulation of ...

08:30 EDT 29 Jun 2017 | BioMedReports - Blog

The Phase 1 trial evaluated the safety, tolerability and PK of ralinepag XR tablets, given as single daily doses, at three dose levels, to 12

Read more...

Original Article: Arena Pharmaceuticals Completes Trial Comparing Once-Daily, Extended Release Formulation of ...

NEXT ARTICLE

More From BioPortfolio on "Arena Pharmaceuticals Completes Trial Comparing Once-Daily, Extended Release Formulation of ..."

Advertisement
Quick Search
Advertisement
Advertisement